Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1992 Jan;68(795):1–5. doi: 10.1136/pgmj.68.795.1

Angiotensin converting enzyme inhibitors for hypertension and heart failure?

J G Cleland 1
PMCID: PMC2399306  PMID: 1561182

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cleland J. G., Dargie H. J., Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987 Dec;58(6):572–582. doi: 10.1136/hrt.58.6.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., McAlpine H., Ball S. G., Morton J. J., Robertson J. I., Ford I. Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) 1985 Nov 9;291(6505):1309–1312. doi: 10.1136/bmj.291.6505.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Robertson I., Robertson J. I., East B. W. Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J. 1987 Sep;58(3):230–238. doi: 10.1136/hrt.58.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleland J. G., Henderson E., McLenachan J., Findlay I. N., Dargie H. J. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol. 1991 Mar 1;17(3):733–739. doi: 10.1016/s0735-1097(10)80192-5. [DOI] [PubMed] [Google Scholar]
  7. Cleland J. G. The renin-angiotensin system in heart failure. Herz. 1991 Apr;16(2):68–81. [PubMed] [Google Scholar]
  8. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  9. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  10. D'Agostino R. B., Belanger A. J., Kannel W. B., Cruickshank J. M. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ. 1991 Aug 17;303(6799):385–389. doi: 10.1136/bmj.303.6799.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Di Pasquale P., Barone G., Paterna S., Cannizzaro S., Giubilato A. Efficacy of captopril before thrombolysis in acute myocardial infarction: preliminary findings. Drugs Exp Clin Res. 1990;16(11):581–589. [PubMed] [Google Scholar]
  12. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R. C., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–683. doi: 10.1056/NEJM198903163201101. [DOI] [PubMed] [Google Scholar]
  13. Figueras J., Lidon R. M., Cortadellas J. Metaraminol-induced reversal of acute myocardial ischaemia associated with hypotension and refractory to intravenous nitroglycerin. Eur Heart J. 1991 Jun;12(6):720–725. doi: 10.1093/eurheartj/12.6.720. [DOI] [PubMed] [Google Scholar]
  14. Hall A. S., Winter C., Bogle S. M., Mackintosh A. F., Murray G. D., Ball S. G. The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions. J Cardiovasc Pharmacol. 1991;18 (Suppl 2):S105–S109. [PubMed] [Google Scholar]
  15. Held P. H., Yusuf S., Furberg C. D. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989 Nov 11;299(6709):1187–1192. doi: 10.1136/bmj.299.6709.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kannel W. B. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J. 1987 Sep;8 (Suppl F):23–26. doi: 10.1093/eurheartj/8.suppl_f.23. [DOI] [PubMed] [Google Scholar]
  17. Lichtlen P. R., Hugenholtz P. G., Rafflenbeul W., Hecker H., Jost S., Deckers J. W. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators. Lancet. 1990 May 12;335(8698):1109–1113. doi: 10.1016/0140-6736(90)91121-p. [DOI] [PubMed] [Google Scholar]
  18. Mancini D. M., Eisen H., Kussmaul W., Mull R., Edmunds L. H., Jr, Wilson J. R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991 Mar;83(3):778–786. doi: 10.1161/01.cir.83.3.778. [DOI] [PubMed] [Google Scholar]
  19. McAlpine H. M., Morton J. J., Leckie B., Rumley A., Gillen G., Dargie H. J. Neuroendocrine activation after acute myocardial infarction. Br Heart J. 1988 Aug;60(2):117–124. doi: 10.1136/hrt.60.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pouleur H., Rousseau M. F., Oakley C., Rydén L. Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol. 1991 Jul 1;68(1):71–74. doi: 10.1016/0002-9149(91)90713-u. [DOI] [PubMed] [Google Scholar]
  22. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 1991 Apr 13;337(8746):872–876. doi: 10.1016/0140-6736(91)90202-z. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES